Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Recent developments in neurofibromatosis type 1.

Ming-Jen Lee¹, Dennis A Stephenson

¹Department of Medical Genetics, National Taiwan University Hospital, National Taiwan University School of Medicine, Taipei, Taiwan. mjlee@ha.mc.ntu.edu.tw

Current Opinion in Neurology

|March 14, 2007

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Exploring Pembrolizumab-Induced IM3OS in a Patient With Bladder Cancer.

Pharmacology research & perspectives·2026

Same author

Perfusion defects on thallium-201 scintigraphy in cardiac amyloidosis.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2025

Same author

Evaluating CAR-T cells from neurofibromatosis type 1 (NF1) patients for targeting AXL in malignant peripheral nerve sheath tumors associated with NF1.

British journal of cancer·2025

Same author

Prevalence of NOTCH2NLC and FMR1 Repeat Expansions in Atypical Parkinsonism Compared to Asymptomatic Elderly Individuals.

Movement disorders : official journal of the Movement Disorder Society·2025

Same author

A consensus on the diagnosis and management of neurofibromatosis type 1 in Taiwan.

Journal of the Formosan Medical Association = Taiwan yi zhi·2025

Same author

Machine learning to predict mitochondrial diseases by phenotypes.

Mitochondrion·2025

Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026

Same journal

Editorial introduction.

Current opinion in neurology·2026

Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026

Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026

Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026

Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026

See all related articles

Neurofibromatosis type 1 (NF1) is a common genetic disorder. Recent research clarifies its clinical features, genetic mutations, and the role of neurofibromin in cellular pathways, offering insights into disease mechanisms.

Area of Science:

Genetics
Molecular Biology
Clinical Medicine

Background:

Neurofibromatosis type 1 (NF1), also known as von Recklinghausen disease, is a prevalent hereditary neurocutaneous disorder.
Clinical manifestations include café-au-lait spots, neurofibromas, and central nervous system tumors.

Purpose of the Study:

To review recent clinical and genetic advancements in NF1.
To provide insights into the underlying pathomechanisms of NF1.

Main Methods:

Review of current literature on NF1 clinical and genetic developments.
Discussion of novel mutation detection technologies like DNA chip microarrays.
Exploration of functional analysis methods including patient-derived cell cultures, mouse models, proteomics, and RNA interference.

Related Experiment Videos

Main Results:

The NF1 gene encodes neurofibromin, a protein implicated in various cellular pathways.
Mutations in the NF1 gene vary from single nucleotide substitutions to large deletions.
Neurofibromin influences adenylate cyclase, AKT-mTOR, and Ras-GTPase activating protein pathways, affecting cell motility.

Conclusions:

Advances in understanding NF1's clinical features and molecular genetics are significant.
Insights into NF1 pathomechanisms are emerging from functional studies.
Further research will continue to elucidate the complexities of NF1.